CIK 0001868279
- Non-accelerated filer
- Emerging growth company
ArriVent BioPharma, Inc.
Sign in to watch- Ticker
- AVBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 240-780-6356
- Business address
- 18 CAMPUS BLVD., SUITE 100, NEWTOWN SQUARE, PA, 19073-3269
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-18 | Parsey Merdad Director | Grant or award · Non-Qualified Stock Option (right to buy) | +13,562 | 13,562 | ||
| 2025-06-18 | Parsey Merdad Director | Grant or award · Non-Qualified Stock Option (right to buy) | +15,502 | 15,502 | ||
| 2025-04-28 | Parsey Merdad Director | Grant or award · Stock Option (right to buy) | +28,346 | 28,346 |
Page 1 of 1 · 3 trades